Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The FDA officially removed tirzepatide from the shortage list in December 2024 and removed semaglutide in February 2025
For peptides you plan to use within weeks, refrigeration is adequate
Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor-I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion
On August 28, 2025, the US Food and Drug Administration (FDA) approved Teva Pharmaceuticals generic to Novo Nordisks Saxenda (liraglutide injection)
US$ 27.44
US$ 28.26
US$ 27.28
